BICO (Q3 Review): A return to organic growth and adjusted EBITDA profitability - Redeye

Redeye updates its estimates and fair value range following BICO’s Q3 2025 report showing a return to organic growth in line with our projections. It also showed a slight beat on sales and adjusted EBITDA compared to our estimates, on account of stronger-than-anticipated Lab Automation sales. BICO trades at an EV/S of 0.5x and an EV/EBITDA of 12x on Redeye's 2026e projections.

Länk till analysen i sin helhet: https://www.redeye.se/research/1135204/bico-q3-review-a-return-to-organic-growth-and-adjusted-ebitda-profitability?utm_source=finwire&utm_medium=RSS